In addition, T cell immunity and B cell immune responses to selected epitopes of MUC1 from ovarian, breast, pancreatic and colon cancer patients have been demonstrated [11-13], as have circulating immune complexes to MUC1 in the serum of breast and ovarian carcinoma patients [14]. This evidence concerns the gene MUC1 and malignant colon neoplasm.